19.09.2018
- With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service...
12.02.2015
- Almac Group today announced a $7 million investment in a significant collaborative research and development expansion with Queens University Belfast (QUB) supported by Invest...
11.09.2014
- Almac, the contract development and manufacturing organization based at Craigavon, UK, has announced its "high level" participation in a synthetic biology project to develop novel...
16.01.2014
- Moving Away - Many would argue that the future of pharmaceutical growth in the coming years will come from emerging markets; U.S. pharma sales have been sluggish recently with a...
11.06.2013
- Craigavon-based pharmaceutical company Almac has announced a further commercial manufacturing expansion. Together with the recent completion of a new non-GMP drug development...
19.02.2013
- In October 2012, Almac announced a collaboration agreement with DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM in the field of...
14.01.2013
- Almac is pleased to announce the expansion of its drug product Pharmaceutical Development services with the creation of a new non-GMP formulation development facility and two new...
23.10.2012
- In response to client requirements, Almac's expansion of their API manufacturing facility at its European Headquarters in Craigavon, UK is near completion, and will be operational...
